United States Pneumococcal Vaccine Market - Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2025


22nd September 2018 - United States Pneumococcal Vaccines Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types, and its applications are increasing across the globe. Pneumococcal Vaccines, as the name suggests, guard against the bacteria termed as “Streptococcus pneumoniae”. Their use could check certain cases of meningitis, pneumonia, and sepsis. The polysaccharide vaccines and conjugate vaccines are two types of pneumococcal vaccines. In addition, under the skin or into the muscle this pneumococcal injection is given.

             

Furthermore, through the vaccination, the prevention of the disease is one of the safest ways and cost-effective. Pneumococcus is one of the leading causes of pneumonia, blood infection, meningitis, otitis media, and sinusitis. It is one of the leading infectious diseases. With a rise in pneumococcal disease due to causative serotype, the need for vaccines with larger coverage has enlarged.


Additionally, the companies are also working on introducing new and inexpensive Pneumococcal Vaccines particularly for emerging countries. There has also been a rise in investment in the research and development activities to produce vaccines at lower cost. United States Pneumococcal Vaccines Industry is categorized based on product type, applications, and geography. United States Pneumococcal Vaccines Market is categorized based on product types such as Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23).

United States Pneumococcal Vaccines Market is categorized based on application into Pneumonia, Meningitis, and Sepsis. United States Pneumococcal Vaccines Industry is categorized based on geography into The West, The Southwest, The Middle Atlantic, New England, The South and The Midwest. Some of the key players that fuel the growth of the United States Pneumococcal Vaccines Market include Celgene Corporation, Pfizer, Merck, Genocea Biosciences, Eli Lilly, AstraZeneca, Nuron Biotech, Beijing Minhai Biotechnology, Sanofi Pasteur, Abera, S K Chemicals, Baxter, Biken, Sanofi, GlaxoSmithKline, Sinovac, Panacea Biotec, Genentech, Immunobiology, Valneva Austria, Biogen. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Market Segment:

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Pneumococcal Vaccine in these regions, from 2013 to 2025 (forecast).

United States Pneumococcal Vaccine market competition by top manufacturers/players, with Pneumococcal Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• MSD
• Sanofipasteur
• CDIB
• Pfizer
• GSK




Comments

Popular posts from this blog

Gardening Equipment Market Scope, Demands, Technological Development and Competitive Insights to 2025

Squalene Industry In-depth Analysis and Forecast Report, 2030

Thrust Vector Control System (TVC) Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025